Skip to content

Comparison of effectiveness of two drugs (palonosetron and ondansetron) in prevention of vomiting in children receiving chemotherapy.

Comparison of palonosetron with ondansetron, with respect to clinical efficacy in prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/03/004492
Enrollment
100
Registered
2014-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pediatric cancer patients on chemotherapy

Interventions

Intervention1: Palonosetron: We will use palonosetron (5 mcg/kg/dose (max. 250 mcg) single dose for 72 hours) and dexamethasone (5 mg/m2/dose, max. 8 mg, 12 hourly for duration of chemotherapy) for C

Sponsors

Christian Medical College Fluid Grant
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children and adolescents with malignancy receiving moderately or highly emetogenic chemotherapy 2. Expected to receive at least 1-2 chemotherapy cycles (effect on 2nd cycle will be studied if 2 or more cycles were given. 3. Corticosteroid containing chemotherapy regimens will be included but dexamethasone will not be given additionally for antiemetic purpose.

Exclusion criteria

Exclusion criteria: 1. Age 2. Intracranial malignancies/disorders/use of anticonvulsants 3. Abdominal or cranial irradiation 4. Nausea/vomiting/antiemetic use within 24 hours before 5. chemotherapy 5. Hepatic/renal/cardiovascular impairment 6. Electrolyte imbalance

Design outcomes

Primary

MeasureTime frame
Zero CINV (chemotherapy induced nausea and vomiting) for early (within 24 hour), Delayed vomiting (24-120 hours) and overall (0-120 hours) period after completion of chemotherapy.Timepoint: 24 hrs and 120 hours

Secondary

MeasureTime frame
Adverse eventTimepoint: 24 hrs and 120 hours;CTCAE Grading of nausea and vomiting- Grading of Nausea (only more than 3 years age) â?¢ Loss of appetite- grade 1 â?¢ Oral intake decreased-grade 2 â?¢ Inadequate oral caloric or fluid intake- grade 3 Grading of vomiting: no of episodes in 24 hours (1 episode is defined as any vomiting separated by no more than 5 min interval.) â?¢ 1 episode -grade 1, â?¢ 2 â?? 5 episodes-grade 2, â?¢ â?¥6 episodes -grade 3, â?¢ Life-threatening -grade 4, â?¢ Death-grade 5.Timepoint: 24 hrs and 120 hours;Effect on anticipatory nausea or vomiting (nausea or vomiting on day 1 of chemotherapy before starting chemotherapy) in next cycle of chemotherapyTimepoint: 24 hrs and 120 hours;Overall satisfaction with the nausea-vomiting experience on a four-point Likert scale (dissatisfied, neutral, satisfied, and highly satisfied) at the time of discharge from ward/day care.Timepoint: 24 hrs and 120 hours;Use of rescue medications (for grade 2 or more nausea/vomiting)Timepoint: 24 hrs and 120 hours

Countries

India

Contacts

Public ContactNARENDRA KUMAR CHAUDHARY

Christian Medical College, Vellore

drnarendrapgi@rocketmail.com9443350635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026